Healthcare · Active clinical trials
Egypt's pharmaceutical sector, the largest in the Arab world, is barely involved in active clinical research — in 2026 it recorded 75 units trials. This ranks 36 out of 197 countries. Key reasons include weak regulatory frameworks, a shortage of qualified coordinators, and competition from more advanced centers in Israel and the UAE. Instead, Egypt focuses on generic drug and vaccine production for domestic and African markets.
Data for 2026 · unit: units
Position
#36 / 197
Egypt world ranking
Country position on the scale from last to first place for this indicator.
EG
#36
#197#1
Trend
Change over time
Change in indicator over the available period.
2
1990
8
2000
25
2010
60
2020
30
2025
75
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Egypt stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Egypt — how much?
Based on 2026 data — 75 units. This is rank #36 out of 197 countries.
What is Egypt's rank by Active clinical trials?
Egypt ranks #36 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Egypt?
Over the available period the indicator changed from 2 to 75 units.